BioNet’s Recombinant Pertussis Vaccine Submitted to European Medicines Agency (EMA)

Contributed by: Business Wire

Tags

Health

Other Science

General Health

Research

Science

Pharmaceutical

Biotechnology

Recombinant Pertussis Vaccine

More Like This

Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union

Moderna Submits Regulatory Application to the European Medicines Agency for Its Updated COVID-19 Vaccine

EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)

Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)

Intravacc announces publication of In Vitro alternative to replace animal pyrogen test for vaccines

Germany Issues Award to IAVI to Support Development of the MTBVAC Tuberculosis Vaccine Candidate

GlobeNewswire associated0

Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention